Laboratory Safety of Dupilumab in Patients Aged 6 to 11 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial
mediaposted on 03.08.2021, 02:15 authored by Amy S. Paller, Andreas Wollenberg, Elaine Siegfried, Diamant Thaçi, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Xian Sun, John O’Malley, Faisal A. Khokhar, Jignesh Vakil, Ashish Bansal, Karli Rosner, Brad Shumel, Noah A. Levit
For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021